QUOTED. March 15, 2018. Pamela Spence.
Check out what Ernst & Young’s Pamela Spence had to say about the business threat to health-care firms from the tech world and how companies must respond.
"To seize the upside of disruption in this transformative age, life-sciences companies must look beyond novel drugs and devices, and invest, participate in or build platforms of care." –Pamela Spence, global life-sciences industry leader, Ernst & Young
Click here for a free trial of Medtech Insight